Navigation Links
CVS Caremark Announces Interim Leadership for Retail Business
Date:1/18/2011

WOONSOCKET, R.I., Jan. 18, 2011 /PRNewswire-FirstCall/ -- CVS Caremark (NYSE: CVS) today announced that it has appointed its two highest ranking retail executives to jointly lead its CVS/pharmacy business, reporting directly to Larry Merlo, President and Chief Operating Officer of CVS Caremark. Effective immediately, Mike Bloom, EVP Merchandising and Supply Chain, and Scott Baker, EVP Internal Operations and Real Estate, will take over the management of the company's retail business for its 7,100 stores across the country.   Bloom and Baker are assuming these responsibilities on an interim basis pending completion of the Company's previously announced search for a new President of CVS/pharmacy.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

Mike Bloom is a seasoned retail executive with more than 30 years of retail experience, 20 of them with CVS/pharmacy. As the senior CVS/pharmacy executive with direct oversight for merchandising and supply chain activities, Bloom leads an integrated end-to-end network managing store layout as well as the selection, purchasing, inventory and supply of product throughout the company's retail locations as well as managing the company's visual merchandising and pricing departments. In addition to his current role, Bloom will now assume responsibility for advertising and marketing.

Scott Baker, whose tenure with CVS/pharmacy spans more than 25 years, has held a variety of important senior roles including SVP of Retail Operations and head of the company's East retail field operations. Baker, a pharmacist by training, will now assume responsibility for all of the company's retail field organizations and pharmacy operations.

"As the company's succession planning process moves forward and I have assumed more enterprise-wide responsibilities, we made the decision to delegate the day-to-day operations of our Retail business to two of our most senior retail executives," noted Merlo. "What has remained clear throughout our search for a new President of CVS/pharmacy is that we are very fortunate to have a strong, stable group of senior leaders supporting our business. This team of individuals has helped shape our direction and deliver industry-leading results and has consistently demonstrated the highest levels of leadership and teamwork. I expect this success to continue into the future as Mike and Scott lead the retail organization."

The company also announced that it has made the decision to resume its search for a new President of CVS/pharmacy. Merlo added, "I am confident we will find the right individual for this important role."

About CVS CaremarkCVS Caremark is the largest pharmacy health care provider in the United States. Through our integrated offerings across the entire spectrum of pharmacy care, we are uniquely positioned to provide greater access, to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 64,000 pharmacies, including approximately 7,100 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical expertise includes one of the industry's most comprehensive disease management programs. General information about CVS Caremark is available through the Company's Web site at http://info.cvscaremark.com.Contacts:Eileen Howard DunnCorporate Communications(401) 770-4561Carolyn CastelCorporate Communications(401) 770-5717ccastel@cvs.comNancy ChristalInvestor Relations(914) 722-4704
'/>"/>

SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Study Finds Patients with Complex Therapies Struggle to Stay Adherent to their Medications
2. CVS Caremark Study Finds Medication Adherence Leads to Lower Health Care Costs, Even After Accounting for Increased Prescription Drug Spending
3. CVS CAREMARK to Purchase Universal Americans Medicare Part D Business
4. CVS Caremark to Present at the 29th Annual J.P. Morgan Healthcare Conference
5. New CVS Caremark Study Finds Health Information Technology May Help Promote Adherence, But More Information and Direction Needed
6. CVS Caremark Customer Care Team Awarded Silver Medal for Best Customer Service at Contact Center Worlds Global Top Ranking Performers Conference
7. CVS Caremark Research Finds Correlation Between Amount of Patient Co-pay and Prescription Abandonment
8. CVS Caremark Reiterates Support for FDA Implementation of Approval Pathway for Biogeneric Drugs
9. CVS Caremark to Present at Credit Suisse Annual Healthcare Conference
10. CVS Caremark Corporation to Hold Third Quarter 2010 Conference Call
11. CVS Caremark Research Highlights How Innovative Plan Designs Help Clients Reduce Drug Spend and Improve Generic Dispensing Rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray ... showcase a healthy CAGR during the forecast period ... in the global digital mobile X-Ray devices market, which is ... in 2017, expanding at a CAGR of 7% over the ... $ opportunity of more than US$ 100 Mn in 2017 ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and ... its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
Breaking Medicine News(10 mins):